Discordance in lymphoid tissue recovery following stem cell transplantation in rhesus macaques: an in vivo imaging study

RE Donahue, S Srinivasula, N Uchida… - Blood, The Journal …, 2015 - ashpublications.org
RE Donahue, S Srinivasula, N Uchida, I Kim, A St. Claire, G Duralde, P DeGrange…
Blood, The Journal of the American Society of Hematology, 2015ashpublications.org
Ionizing irradiation is used routinely to induce myeloablation and immunosuppression.
However, it has not been possible to evaluate the extent of ablation without invasive biopsy.
For lymphoid recovery, peripheral blood (PB) lymphocytes (PBLs) have been used for
analysis, but they represent< 2% of cells in lymphoid tissues (LTs). Using a combination of
single-photon emission computed tomography imaging and a radiotracer (99mTc-labeled
rhesus immunoglobulin G1 anti-CD4R1 (Fab′) 2), we sequentially imaged CD4+ cell …
Abstract
Ionizing irradiation is used routinely to induce myeloablation and immunosuppression. However, it has not been possible to evaluate the extent of ablation without invasive biopsy. For lymphoid recovery, peripheral blood (PB) lymphocytes (PBLs) have been used for analysis, but they represent <2% of cells in lymphoid tissues (LTs). Using a combination of single-photon emission computed tomography imaging and a radiotracer (99mTc-labeled rhesus immunoglobulin G1 anti-CD4R1 (Fab′)2), we sequentially imaged CD4+ cell recovery in rhesus macaques following total body irradiation (TBI) and reinfusion of vector-transduced, autologous CD34+ cells. Our results present for the first time a sequential, real-time, noninvasive method to evaluate CD4+ cell recovery. Importantly, despite myeloablation of circulating leukocytes following TBI, total depletion of CD4+ lymphocytes in LTs such as the spleen is not achieved. The impact of TBI on LTs and PBLs is discordant, in which as few as 32.4% of CD4+ cells were depleted from the spleen. In addition, despite full lymphocyte recovery in the spleen and PB, lymph nodes have suboptimal recovery. This highlights concerns about residual disease, endogenous contributions to recovery, and residual LT damage following ionizing irradiation. Such methodologies also have direct application to immunosuppressive therapy and other immunosuppressive disorders, such as those associated with viral monitoring.
ashpublications.org